Cugene
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
411 Waverley Oaks Rd Ste 142, Waltham, M...Phone Number
(781) 893-5800Website
www.cugene.comRevenue
<$5 MillionIndustry
About Cugene
Cugene Inc. is a Boston-based clinical stage biotechnology company focused on developing next-generation medicines for cancer and autoimmune diseases. The company utilizes its expertise in biology and precision protein engineering to create biologics-based therapeutics that target regulatory T cells and effector cells in autoimmune disorders, as well as T cells and tumor infiltrating lymphocytes in oncology. Cugene's innovative technologies, including CUG252, TILKine, and VitoKine, aim to restore immune homeostasis and enhance anti-tumor responses. With a team of leading experts in the biopharmaceutical industry, Cugene is dedicated to addressing unmet medical needs through science-driven drug discovery.Explore more
Cugene Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Cugene
Compare insights from companies similar to Cugene, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cugene Tech Stack
A closer look at the technologies used by Cugene
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cugene
Sign Up For FreeTo access detailed company insights
Cugene Inc. is a Boston-based clinical stage biotechnology company focused on developing next-generation medicines for cancer and autoimmune diseases. The company utilizes its expertise in biology and precision protein engineering to create biologics-based therapeutics that target regulatory T cells and effector cells in autoimmune disorders, as we... Read More
